Transplant;Failure,Kidney
26
5
8
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.8%
1 terminated out of 26 trials
90.0%
+3.5% vs benchmark
8%
2 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (26)
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
Dietary Intervention to Improve Kidney Transplant Outcomes
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
Continuous Spinal Anesthesia in Renal Transplantation
Enhancing Renal Graft Function During Donor Anesthesia
Abdominal Wall Transplant
The Effect of Mandala Therapy on Anxiety and Comfort in Kidney Transplant Recipients
Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Immunosuppression Personalization: an Open-labeled Multicenter Randomized Controlled Study
Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA
Impact of Microvascular Inflammation on Kidney Allograft Outcome
EASE-SOT Pilot Study
Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Effectiveness of 20m-MB in KTR Symptom Control
The Learning Curve for Retroperitoneoscopic Donor Nephrectomy
Real-time Monitoring of Kidney Grafts on Hypothermic Machine Perfusion
Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
APOL1 Gene Variants in African American Kidney Transplant Recipients